Interventions to Address Disparities in Liver Diseases an...
Federal opportunity from Public Agency. Place of performance: United States.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.
Applicable Wage Determinations
SAM WDOL references matched to this opportunity's location and scope language.
Point of Contact
Agency & Office
Description
This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States. The research should focus on addressing disparities in liver diseases and liver cancer, and should be based on the principles of health equity and social determinants of health. Some possible areas of focus include:
• Developing and testing interventions to reduce disparities in li... | Title: Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional), Agency: U.S. National Institutes of Health, State: United States of America, Open Date: 5/13/2024, Close Date: 1/7/2028, Last Updated Date: 3/2/2026
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
FAQ
How do I use the Market Snapshot?
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
Is the data live?
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
What do P10 and P90 mean?
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.